Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK
|
BSE: 532296
|
ISIN: INE935A01035
|
Industry: Pharmaceuticals
|
Expensive Underperformer
1342.4000
-14.40
(
-1.06
%)
NSE
Apr 17, 2025
15:31 PM
26.68% Fall from 52W High
Volume:
613.4K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Glenmark Pharmaceuticals Ltd.
18 Jun 2024
1342.40
-1.06%
GLENMARK PHARMACEUTICALS
Hold:
Glenmark Pharmaceuticals Ltd.
by
Geojit BNP Paribas
Target: 1319 | Target met
Target
Geojit BNP Paribas
Glenmark Pharmaceuticals Ltd. is trading below all available SMAs
More from Glenmark Pharmaceuticals Ltd.
Recommended
Five Interesting Stocks Today - April 17, 2025
The Baseline |
17 Apr 2025
Market closes higher, HDFC AMC's net profit beats Forecaster estimates by 8%
Trendlyne Marketwatch |
17 Apr 2025
Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals
|
29 Jun 2020